Synergistic antitumor activity of sorafenib and MG149 in hepatocellular carcinoma cells

Advanced hepatocellular carcinoma (HCC) is among the most challenging cancers to overcome, and there is a need for better therapeutic strategies. Among the different cancer drugs that have been used in clinics, sorafenib is considered the standard first-line drug for advanced HCC. Here, to identify...

Descripción completa

Detalles Bibliográficos
Autores principales: Moon, Byul, Park, Mijin, Cho, Seung-Hyun, Kim, Kang Mo, Seo, Haeng Ran, Kim, Jeong-Hoon, Kim, Jung-Ae
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society for Biochemistry and Molecular Biology 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9623241/
https://www.ncbi.nlm.nih.gov/pubmed/35880431
http://dx.doi.org/10.5483/BMBRep.2022.55.10.037

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9623241/
https://www.ncbi.nlm.nih.gov/pubmed/35880431
http://dx.doi.org/10.5483/BMBRep.2022.55.10.037

Ejemplares similares